| Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease EF Fang, Y Hou, K Palikaras, BA Adriaanse, JS Kerr, B Yang, S Lautrup, ... Nature neuroscience 22 (3), 401-412, 2019 | 1184 | 2019 |
| Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent NH Greig, T Utsuki, DK Ingram, Y Wang, G Pepeu, C Scali, QS Yu, ... Proceedings of the National Academy of Sciences 102 (47), 17213-17218, 2005 | 805 | 2005 |
| Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial D Athauda, K Maclagan, SS Skene, M Bajwa-Joseph, D Letchford, ... The Lancet 390 (10103), 1664-1675, 2017 | 684 | 2017 |
| Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms JS Kerr, BA Adriaanse, NH Greig, MP Mattson, MZ Cader, VA Bohr, ... Trends in neurosciences 40 (3), 151-166, 2017 | 679 | 2017 |
| An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript JT Rogers, JD Randall, CM Cahill, PS Eder, X Huang, H Gunshin, L Leiter, ... Journal of Biological Chemistry 277 (47), 45518-45528, 2002 | 661 | 2002 |
| GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism Y Li, TA Perry, MS Kindy, BK Harvey, D Tweedie, HW Holloway, K Powers, ... Proceedings of the National Academy of Sciences 106 (4), 1285-1290, 2009 | 644 | 2009 |
| Drug discovery and development: Role of basic biological research RC Mohs, NH Greig Alzheimer's & Dementia: Translational Research & Clinical Interventions 3 (4 …, 2017 | 634 | 2017 |
| A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase NH Greig, T Utsuki, Q Yu, X Zhu, HW Holloway, TA Perry, B Lee, ... Current medical research and opinion 17 (3), 159-165, 2001 | 574 | 2001 |
| Butyrylcholinesterase: an important new target in Alzheimer's disease therapy NH Greig, DK Lahiri, K Sambamurti International psychogeriatrics 14 (S1), 77-91, 2002 | 503 | 2002 |
| Running-induced systemic cathepsin B secretion is associated with memory function HY Moon, A Becke, D Berron, B Becker, N Sah, G Benoni, E Janke, ... Cell metabolism 24 (2), 332-340, 2016 | 501 | 2016 |
| Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats M Szayna, ME Doyle, JA Betkey, HW Holloway, RGS Spencer, NH Greig, ... Endocrinology 141 (6), 1936-1941, 2000 | 437 | 2000 |
| Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4 TA Perry, NJ Haughey, MP Mattson, JM Egan, NH Greig Journal of Pharmacology and Experimental Therapeutics 302 (3), 881-888, 2002 | 428 | 2002 |
| Cholinesterases: roles in the brain during health and disease CG Ballard, NH Greig, AL Guillozet-Bongaarts, A Enz, S Darvesh Current Alzheimer Research 2 (3), 307-318, 2005 | 421 | 2005 |
| N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer’s disease, vascular dementia and Parkinson’s disease D Olivares, V K Deshpande, Y Shi, D K Lahiri, N H Greig, J T Rogers, ... Current Alzheimer Research 9 (6), 746-758, 2012 | 417 | 2012 |
| Glucagon‐like peptide‐1 decreases endogenous amyloid‐β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron TA Perry, DK Lahiri, K Sambamurti, D Chen, MP Mattson, JM Egan, ... Journal of neuroscience research 72 (5), 603-612, 2003 | 413 | 2003 |
| A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide C Culmsee, X Zhu, QS Yu, SL Chan, S Camandola, Z Guo, NH Greig, ... Journal of neurochemistry 77 (1), 220-228, 2001 | 395 | 2001 |
| Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer’s disease R J Baranello, K L Bharani, V Padmaraju, N Chopra, D K Lahiri, N H Greig, ... Current Alzheimer Research 12 (1), 32-46, 2015 | 372 | 2015 |
| GLP-1 receptor stimulation reduces amyloid-β peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease Y Li, KB Duffy, MA Ottinger, B Ray, JA Bailey, HW Holloway, D Tweedie, ... Journal of Alzheimer's disease 19 (4), 1205-1219, 2010 | 357 | 2010 |
| A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells TA Perry, DK Lahiri, D Chen, JIE Zhou, KTY Shaw, JM Egan, NH Greig Journal of Pharmacology and Experimental Therapeutics 300 (3), 958-966, 2002 | 356 | 2002 |
| TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation K Belarbi, T Jopson, D Tweedie, C Arellano, W Luo, NH Greig, S Rosi Journal of neuroinflammation 9, 1-13, 2012 | 324 | 2012 |
